IGES Experten vor Ort
30.03.22
Dr. Elizabeth Brock | IGES Gruppe
Moderation
Early Trial Planning in Times of Pay-for-Performance Agreements & European HTA Harmonization
This workshop will focus on innovative reimbursement for high-cost therapies in Europe. It will outline how mid-sized biotech companies can successfully bring their innovations into the European reimbursement systems through early study planning. Special emphasis is placed on the harmonization of the health technology assessment (hta) procedures and the resulting study design requirements. Success factors for pay-for-performance models are also presented.
Panel Discussion with
Peter Braunhofer | Alexion Pharmaceuticals
Mike Ryan | EVERSANA
Veranstaltung: BIO-EUROPE
SPRING
Digital-Veranstaltung
Veranstaltungssprache: Englisch
Zeit: 13.30 - 14.30 Uhr
